ERC-124

N/A

Report date: 2023/07/20 14:14:09

Base Information

Drug NameERC-124
Drug Alias NameERC-124
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionCell replacementsInterferon gamma receptor antagonists
TargetsInterferon gamma receptor
Therapy Area/IndicationsPeripheral Vascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedistem LaboratoriesShanghai Jiafu Medical Instrument Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedistem Inc
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A